A Review of Research Progress of Pregnancy with Twins with Preeclampsia

References

• Wei J, Qi-Jun W, Zhang T-N, et al. Complications in multiple gestation pregnancy: a cross-sectional study of ten maternal-fetal medicine centers in China. Oncotarget. 2016;7(21):30797.
   PubMedGoogle Scholar
• Grantz KL, Kawakita T, Lu Y-L, Newman R, Berghella V, Caughey A. SMFM SPECIAL STATEMent: state of the science on multifetal gestations: unique considerations and importance. Am J Obstet Gynecol. 2019;221(2):B2–B12. doi:10.1016/j.ajog.2019.04.013
   PubMed Web of Science ®Google Scholar
• Narang K, Szymanski LM. Multiple gestations and hypertensive disorders of pregnancy: what do we know? Curr Hypertens Rep. 2021;23:1. doi:10.1007/s11906-020-01107-4
   Web of Science ®Google Scholar
• Stulberg DB, Jackson RA, Freedman LR. Referrals for services prohibited in Catholic health care facilities. Perspect Sex Reprod Health. 2016;48:111–117. doi:10.1363/48e10216
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131. doi:10.1097/01.AOG.0000437382.03963.88
   PubMed Web of Science ®Google Scholar
• Cecil RL, Goldman L, Schafer AI. Goldman’s Cecil Medicine (24th Ed). Philadelphia, PA: Elsevier Saunders; 2012.
   Google Scholar
• Tranquilli AL, Landi B, Giannubilo SR, Sibai BM. Preeclampsia: no longer solely a pregnancy disease. Pregnancy Hypertens. 2012;2(4):350–357. doi:10.1016/j.preghy.2012.05.006
   PubMed Web of Science ®Google Scholar
• Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;338(11):701–705. doi:10.1056/NEJM199803123381101
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974. doi:10.1136/bmj.39335.385301.BE
   PubMed Web of Science ®Google Scholar
• Veerbeek JH, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015;65(3):600–606. doi:10.1161/HYPERTENSIONAHA.114.04850
   PubMed Web of Science ®Google Scholar
• Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre- eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(Suppl 1):1–33. doi:10.1002/ijgo.12802
   PubMed Web of Science ®Google Scholar
• Robillard PY, Dekker G, Iacobelli S, Chaouat G. An essay of reflection: why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology? J Reprod Immunol. 2016;114:44–47. doi:10.1016/j.jri.2015.07.001
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol. 2013;209:544. e1–544.e12. doi:10.1016/j.ajog.2013.08.019
   Web of Science ®Google Scholar
• Rasmussen S, Irgens LM, Espinoza J. Maternal obesity and excess of fetal growth in preeclampsia. BJOG. 2014;121(11):1351–1357. doi:10.1111/1471-0528.12677
   Web of Science ®Google Scholar
• Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol. 1998;147(11):1062–1070. doi:10.1093/oxfordjournals.aje.a009400
   PubMed Web of Science ®Google Scholar
• Li X, Tan H, Huang X, et al. Similarities and differences between the risk factors for gestational hypertension and preeclampsia: a population based cohort study in south China. Pregnancy Hypertens. 2016;6(1):66–71. doi:10.1016/j.preghy.2015.11.004
   Web of Science ®Google Scholar
• Krotz S, Fajardo J, Ghandi S, Patel A, Keith LG. Hypertensive disease in twins pregnancies: a review. Twins Res. 2002;5(1):8–14. doi:10.1375/twin.5.1.8
   Google Scholar
• Francisco C, Wright D, Benkő Z, Syngelaki A, Nicolaides KH. Hidden high rate of preeclampsia in twins compared to singleton pregnancies. Ultrasound Obstet Gynecol. 2017;50(1):88–92. doi:10.1002/uog.17470
   PubMed Web of Science ®Google Scholar
• Wen SW, Demissie K, Yang Q, Walker MC. Maternal morbidity and obstetric complications in triplet pregnancies and quadruplet and higher-order multiple pregnancies. Am J Obstet Gynecol. 2004;191(1):254–258. doi:10.1016/j.ajog.2003.12.003
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of Preeclampsia. N Engl J Med. 2004;350(7):672–683. doi:10.1056/NEJMoa031884
   PubMed Web of Science ®Google Scholar
• Smith-Levitin M, Kowalik A, Birnholz J, et al. Selective reduction of multifetal pregnancies to twins improves outcome over nonreduced triplet gestations. Am J Obstet Gynecol. 1996;175:878–882. doi:10.1016/S0002-9378(96)80017-2
   PubMed Web of Science ®Google Scholar
• Bschier F, Beinder E. Temporary resolution of preeclamptic symptoms after intrauterine death of one twins. Hypertens Pregnancy. 2005;24:313–317. doi:10.1080/10641950500281100
   Web of Science ®Google Scholar
• Okby R, Harlev A, Sacks KN, Sergienko R, Sheiner E. Preeclampsia acts differently in in vitro fertilization versus spontaneous twins. Arch Gynecol Obstet. 2018;297(3):653–658. A retrospective population based study investigating the incidence of Preeclampsia in IVF twins pregnancies; with concluding that it is more common than in spontaneous twins pregnancies. doi:10.1007/s00404-017-4635-y
   PubMed Web of Science ®Google Scholar
• Sites CK, Wilson D, Barsky M, et al. Embryo cryopreservation and preeclampsia risk. Fertil Steril. 2017;108(5):784–790. doi:10.1016/j.fertnstert.2017.08.035
   PubMed Web of Science ®Google Scholar
• Schroeder BM. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician. 2002;66(2):330–331.
   PubMed Web of Science ®Google Scholar
• Zhang HN, Xu QQ, Thakur A, et al. Endothelial dysfunction in diabetes and hypertension: role of microRNAs and long non-coding RNAs. Life Sci. 2018;213:258–268. doi:10.1016/j.lfs.2018.10.028
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Investig. 2003;111:649–658. doi:10.1172/JCI17189
   PubMed Web of Science ®Google Scholar
• Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642–649. doi:10.1038/nm1429
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin andother circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992–1005. doi:10.1056/NEJMoa055352
   PubMed Web of Science ®Google Scholar
• McGinnis R, Steinthorsdottir V, Williams NO, et al. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet. 2017;49:1255–1260. doi:10.1038/ng.3895
   PubMed Web of Science ®Google Scholar
• Gray KJ, Saxena R, Karumanchi SA. Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis. Am J Obstet Gynecol. 2018;218:211–218. doi:10.1016/j.ajog.2017.11.562
   PubMed Web of Science ®Google Scholar
• Bdolah Y, Palomaki GE, Yaron Y, et al. Circulating angiogenic proteins in trisomy 13. Am J Obstet Gynecol. 2006;194:239–245. doi:10.1016/j.ajog.2005.06.031
   PubMed Web of Science ®Google Scholar
• Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;90:10705–10709. doi:10.1073/pnas.90.22.10705
   PubMed Web of Science ®Google Scholar
• Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998;179:1359–1375. doi:10.1016/S0002-9378(98)70160-7
   PubMed Web of Science ®Google Scholar
• Burton GJ. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:12381. doi:10.1136/bmj.l2381
   Web of Science ®Google Scholar
• Yu W, Gao W, Rong D, Wu Z, Khalil RA. Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia. Microcirculation. 2019;26:e12508. doi:10.1111/micc.12508
   Web of Science ®Google Scholar
• Chazara O, Xiong S, Moffett A. Maternal KIR and fetal HLA-C: a fine balance. J Leukoc Biol. 2011;90:703–716. doi:10.1189/jlb.0511227
   PubMed Web of Science ®Google Scholar
• Hiby SE, Apps R, Sharkey AM, et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest. 2010;120(11):4102–4110. doi:10.1172/JCI43998
   PubMed Web of Science ®Google Scholar
• Robillard PY, Dekker GA, Hulsey TC. Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity? Eur J Obstet Gynecol Reprod Biol. 1999;84:37–41. doi:10.1016/S0301-2115(98)00250-4
   PubMed Web of Science ®Google Scholar
• Deen ME, Ruurda LG, Wang J, Dekker GA. Risk factors for preeclampsia in multiparous women: primipaternityversus the birth interval hypothesis. J Matern Fetal Neonatal Med. 2006;19:79–84. doi:10.1080/14767050500361653
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol. 2003;59:161–173. doi:10.1016/S0165-0378(03)00045-7
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Darmochwal-Kolarz D, Suzuki D, et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in preeclampsia. Clin Exp Immunol. 2007;149:139–145. doi:10.1111/j.1365-2249.2007.03397.x
   PubMed Web of Science ®Google Scholar
• Derzsy Z, Prohaszka Z, Rigo JJ, Fust G, Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol Immunol. 2010;47(7–8):1500–1506. doi:10.1016/j.molimm.2010.01.021
   PubMed Web of Science ®Google Scholar
• Jean FR, Richard MB, Sherry DF. The complement system and preeclampsia. Curr Hypertens Rep. 2017;19:2–12. doi:10.1007/s11906-017-0704-7
   Web of Science ®Google Scholar
• Lynch AM, Murphy JR, Byers T, et al. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia. Am J Obstet Gynecol. 2008;198:385. doi:10.1016/j.ajog.2007.10.793
   PubMed Web of Science ®Google Scholar
• Sones JL, Merriam AA, Seffens A, et al. Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia. FASEB J. 2018;32(5):2574–2586. doi:10.1096/fj.201701008R
   Web of Science ®Google Scholar
• Vaught AJ, Braunstein EM, Jasem J, et al. Germline mutations in the alternative pathway of complement predispose to HELLP syndrome. JCI Insight. 2018;3(6):99128. doi:10.1172/jci.insight.99128
   PubMed Web of Science ®Google Scholar
• Vaught AJ, Gavriilaki E, Hueppchen N, et al. Direct evidence of complement activation in HELLP syndrome: alink to atypical hemolytic uremic syndrome. Exp Hematol. 2016;44:390–398. doi:10.1016/j.exphem.2016.01.005
   PubMed Web of Science ®Google Scholar
• Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203:2165–2175. doi:10.1084/jem.20061022
   PubMed Web of Science ®Google Scholar
• Lucovnik M, Blickstein I, Lasic M, et al. Hypertensive disorders during monozygotic and dizygotic twins gestations: a population-based study. Hypertens Pregnancy. 2016;35:1–6. A population based study evaluating the impact of twins zygosity (monozygotic vs dizygotic) on preeclampsia risk and outcomes. The study concludes no difference based on zygosity. doi:10.1080/10641955.2016.1197936
   Web of Science ®Google Scholar
• Rantakallio JSS, Nevalainen JE, West SI, et al. Association of self-reported polycystic ovary syndrome, obesity, and weight gain from adolescence to adulthood with hypertensive disorders of pregnancy: a community-based approach. Hypertension. 2021;77(3):1010–1019. doi:10.1161/HYPERTENSIONAHA.120.15702
   PubMed Web of Science ®Google Scholar
• Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy. 2012;2012:105918. doi:10.1155/2012/105918
   PubMedGoogle Scholar
• Horikoshi M, Beaumont RN, Day FR, et al. Genome-wide associations for birth weight and correlations with adult disease. Nature. 2016;538(7624):248–252. doi:10.1038/nature19806
   PubMed Web of Science ®Google Scholar
• Laine K, Murzakanova G, Sole KB, Pay AD, Heradstveit S, Räisänen S. Prevalence and risk of preeclampsia and gestational hypertension in twins pregnancies: a population-based register study. BMJ Open. 2019;9(7):e029908. doi:10.1136/bmjopen-2019-029908
   PubMed Web of Science ®Google Scholar
• Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twins versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol. 2000;182:938–942. doi:10.1016/s0002-9378(00)70350-4
   PubMed Web of Science ®Google Scholar
• Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for preeclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753. doi:10.1136/bmj.i1753
   PubMed Web of Science ®Google Scholar
• Petersen SH, Bergh C, Gissler M, et al. Time trends in placenta-mediated pregnancy complications after assisted reproductive technology in the Nordic countries. Am J Obstet Gynecol. 2020;223(2). doi:10.1016/j.ajog.2020.02.030
   Web of Science ®Google Scholar
• Henry DE, McElrath TF, Smith NA. Preterm severe preeclampsia in singleton and twin pregnancies. J Perinatol. 2013;33(2). doi:10.1038/jp.2012.74
   Web of Science ®Google Scholar
• Bartnik P, Kosinska-Kaczynska K, Kacperczyk J, et al. Twins chorionicity and the risk of hypertensive disorders: gestational hypertension and Pre-eclampsia. Twins Res Hum Genet. 2016;19:377–382. doi:10.1017/thg.2016.17
   PubMed Web of Science ®Google Scholar
• Sparks TN, Cheng YW, Phan N, et al. Does risk of preeclampsia differ by twins chorionicity? J Matern Fetal Neonatal Med. 2013;26:1273–1277. doi:10.3109/14767058.2013.777701
   PubMed Web of Science ®Google Scholar
• Savvidou MD, Karanastasi E, Skentou C, et al. Twins chorionicity and preeclampsia. Ultrasound Obstet Gynecol. 2001;18:228–231. doi:10.1046/j.0960-7692.2001.00470
   PubMed Web of Science ®Google Scholar
• Hiersch L, Berger H, Okby R, Ray JG, Geary M, McDonald SD. Gestational diabetes mellitus is associated with adverse outcomes in twin pregnancies. Am J Obstet Gynecol. 2019;220(1):102.e1–102.e8. doi:10.1016/j.ajog.2018.10.027
   Web of Science ®Google Scholar
• Svirsky R, Yagel S, Ben-Ami I, Cuckle H, Klug E, Maymon R. First trimester markers of preeclampsia in twins: maternal mean arterial pressure and uterine artery Doppler pulsatility index. Prenat Diagn. 2014;34:956–960. doi:10.1002/pd.4402
   PubMed Web of Science ®Google Scholar
• Chen Q, Izumi A, Minakami H, Sato I. Comparative changes in uterine 5rtery blood flow waveforms in singleton and twin pregnancies. Gynecol Obstet Invest. 1998;45:165–169. doi:10.1159/000009948
   Web of Science ®Google Scholar
• Mourad M, Too G, Gyamfi-Bannerman C, Zork N. Hypertensive disorders of pregnancy in twin gestations complicated by gestational diabetes. J Matern Fetal Neonatal Med. 2021;34(5):720–724. doi:10.1080/14767058.2019.1614160
   PubMed Web of Science ®Google Scholar
• Mor N, Machtinger R, Yinon Y, et al. Outcome of two sequential singleton pregnancies and twin pregnancies among primiparous women at advanced age undergoing IVF. Arch Gynecol Obstet. 2020;302(5):1113–1119. doi:10.1007/s00404-020-05700-5
   Web of Science ®Google Scholar
• Aviram A, Giltvedt MK, Sherman C, et al. The role of placental malperfusion in the pathogenesis of preeclampsia in dichorionic twin and singleton pregnancies. Placenta. 2018;70:41–49. doi:10.1016/j.placenta.2018.09.002
   PubMed Web of Science ®Google Scholar
• Foo JY, Mangos G, Brown M. OS096. Characteristics of hypertensive disorders in twin versus singleton pregnancies. Pregnancy Hypertens. 2012;2(3):230–231. doi:10.1016/j.preghy.2012.04.097
   Google Scholar
• Foo JY, Mangos GJ, Brown MA. Characteristics of hypertensive disorders in twin versus singleton pregnancies. Pregnancy Hypertens. 2013;3(1):3–9. doi:10.1016/j.preghy.2012.05.005
   PubMed Web of Science ®Google Scholar
• Connolly KA, Factor SH, Getrajdman CS, Bigelow CA, Weintraub AS, Stone JL. Maternal clinical disease characteristics and maternal and neonatal outcomes in twin and singleton pregnancies with severe preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2016;201:36–41. doi:10.1016/j.ejogrb.2015.11.031
   PubMed Web of Science ®Google Scholar
• Myatt L, Roberts JM. Preeclampsia: syndrome or disease? Curr Hypertens Rep. 2015;17(11):83. doi:10.1007/s11906-015-0595-4
   PubMed Web of Science ®Google Scholar
• English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7–12. doi:10.2147/IBPC.S50641
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799. doi:10.1016/S0140-6736(05)71003-5
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659.
   PubMed Web of Science ®Google Scholar
• CLASP (Collaborative Low-dose Aspirin Study in Pregnancy)Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet. 1994;343:619–629. doi:10.1016/S0140-6736(94)92633-6
   Web of Science ®Google Scholar
• Sibai BM, Caritis SN, Thom E, Shaw K, McNellis D; National Institute of Child Health and Human Developmental Maternal-Fetal Medicine Network. Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. Am J Obstet Gynecol. 1995;172:1553–1557. doi:10.1016/0002-9378(95)90495-6
   Web of Science ®Google Scholar
• World Health Organization. WHO recommendations for prevention and treatment of Pre-eclampsia and eclampsia; 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf. Accessed October 5, 2015.
   Google Scholar
• Panagodage S, Yong HEJ, Da Silva Costa F. Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia. Am J Pathol. 2016;186:3217–3224. doi:10.1016/j.ajpath.2016.08.010
   PubMed Web of Science ®Google Scholar
• Goodnight W, Newman R; Society of Maternal-Fetal Medicine. Optimal nutrition for improved twins pregnancy outcome. Obstet Gynecol. 2009;114:1121–1134. doi:10.1097/AOG.0b013e3181bb14c8
   PubMed Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125:911–919. doi:10.1161/CIRCULATIONAHA.111.054361
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA, et al. Maternal plasma concentrations of angiogenic/antiangiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med. 2011;24:1187–1207. doi:10.3109/14767058.2011.589932
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1: plGFratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22. doi:10.1056/NEJMoa1414838
   PubMed Web of Science ®Google Scholar
• Rana S, Schnettler WT, Powe C, et al. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013;32:189–201. doi:10.3109/10641955.2013.784788
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine F, et al. Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia. Obstet Gynecol. 2016;128:261–269. doi:10.1097/AOG.0000000000001525
   PubMed Web of Science ®Google Scholar
• Saleh L, van den Meiracker AH, Geensen R, et al. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed preeclampsia. Ultrasound Obstet Gynecol. 2018;51:751–757. doi:10.1002/uog.17547
   PubMed Web of Science ®Google Scholar
• Duhig KE, Myers J, Seed PT, et al.; PARROT trial group. Placental growth factor testing to assess women with suspected preeclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019;393:1807–1818. doi:10.1016/S0140-6736(18)33212-4
   PubMed Web of Science ®Google Scholar
• McCoy S, Baldwin K. Pharmacotherapeutic options for the treatment of preeclampsia. Am J Health Syst Pharm. 2009;66:337–344. doi:10.2146/ajhp080104
   Web of Science ®Google Scholar
• Gyamfi-Bannerman C, Gantt AB, Miller RS. ACOG Committee Opinion No 764: medically indicated late-preterm and early-term deliveries. Obstet Gynecol. 2019;133:e151–e155. doi:10.1097/AOG.0000000000003083
   PubMed Web of Science ®Google Scholar
• NICE. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. London: National Institute for Health and Care Excellence; 2010.
   Google Scholar
• Koopmans CM, Bijlenga D, Groen H. Induction of labour versus expectant monitoring for gestational hypertension or mild preeclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–988. doi:10.1016/S0140-6736(09)60736-4
   PubMed Web of Science ®Google Scholar
• Brown MA, Magee LA, Kenny LC. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2018;13:291–310. doi:10.1016/j.preghy.2018.05.004
   PubMed Web of Science ®Google Scholar
• Gamble DT, Brikinns B, Myint PK, Bhattacharya S. Hypertensive disorders of pregnancy and subsequent cardiovascular disease: current national and international guidelines and the need for future research. Front Cardiovasc Med. 2019;6:55. doi:10.3389/fcvm.2019.00055
   PubMed Web of Science ®Google Scholar